HIF-prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques

HIF-prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques
复制标题

DOI:
10.1182/blood-2007-02-073254
复制
发表时间:
2007-09-15
期刊:
影响因子:
20.3
通讯作者:
Tisdale, John F.
Tisdale, John F.
中科院分区:
医学1区
文献类型:
--
作者:
Hsieh, Matthew M.;Linde, N. Seth;Tisdale, John F.

文献摘要

被引文献

相似文献

缺氧诱导因子(HIF)通路在减轻缺氧的有害影响中至关重要。HIF-α是氧敏感机制的重要组成部分,在常氧条件下通过HIF-脯氨酰羟化酶的羟基化作用进行降解。几种HIF-脯氨酰羟化酶抑制剂(PHIs)诱导促红细胞生成素(EPO)的表达在体外和小鼠中,与峰值EPO表达范围从5.6到207倍以上的控制动物。此外,如通过流式细胞术测定的,几种PHI在体外诱导原代人红系细胞中的胎儿血红蛋白(HbF)表达。在非人灵长类动物模型中进一步检测了一种PHI(FG-2216)(不伴和伴慢性静脉切开术)。FG-2216具有经口生物利用度,并在体内诱导显著且可逆的Epo诱导(60 mg/kg时为82- 309倍)。雄性恒河猴长期经口给药耐受性良好,显著增加红细胞生成,并预防每周抽血诱导的贫血。此外,通过流式细胞术证实了含HbF的红细胞和网织红细胞的适度增加,但通过高压液相色谱法(HPLC)未证实HbF的显著增加。HIF PHI代表了一类新的分子,其在先天性和获得性贫血中具有广泛的潜在临床应用。
The hypoxia-inducible factor (HIF) pathway is crucial in mitigating the deleterious effects of oxygen deprivation. HIF-alpha is an essential component of the oxygen-sensing mechanisms and under normoxic conditions is targeted for degradation via hydroxylation by HIF-prolyl hydroxylases. Several HIF-prolyl hydroxylase inhibitors (PHIs) induced erythropoietin (epo) expression in vitro and in mice, with peak epo expression ranging from 5.6- to 207-fold above control animals. Furthermore, several PHIs induced fetal hemoglobin (HbF) expression in primary human erythroid cells in vitro, as determined by flow cytometry. One PHI, FG-2216, was further tested in a nonhuman primate model without and with chronic phlebotomy. FG-2216 was orally bioavallable and induced significant and reversible Epo induction in vivo (82- to 309-fold at 60 mg/kg). Chronic oral dosing in male rhesus macaques was well tolerated, significantly increased erythropolesis, and prevented anemia induced by weekly phlebotomy. Furthermore, mod- est increases in HbF-containing red cells and reticulocytes were demonstrated by flow cytometry, though significant increases in HbF were not demonstrated by high-pressure liquid chromatography (HPLC). HIF PHIs represent a novel class of molecules with broad potential clinical application for congenital and acquired anemias.